
SynBioBeta Speaker
Joshua Meier
CEO & Co-founder
Chai Discovery
May 2026, SynBioBeta
Speaker
Joshua Meier is the co-founder and CEO of Chai Discovery, a biotech company building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules. Prior to founding Chai, Joshua was the Chief AI Officer at Absci, where he spearheaded the company's transformation into AI Drug Discovery and built robust departments of top-tier AI scientists and engineers. Prior to Absci, Joshua was a senior researcher at Facebook AI Research, where he co-founded and led the platform for evolutionary-scale protein language modeling. The panel Joshua is speaking on will focus on the topic of how AI is reshaping how biopharma discovers, develops, and advances therapeutic agents across the full lifecycle, from early design to translational strategy and clinical asset development.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include

Join for the latest
SynBioBeta event updates.








































































































































































































































































































































































































































